NASDAQ:RCM

R1 RCM (RCM) Stock Forecast, Price & News

$16.81

+0.38 (+2.31%)

(As of 06/2/2023 ET)

Compare

Today's Range: $16.49
▼
$16.83
50-Day Range: $14.45
▼
$16.91
52-Week Range: $6.71
▼
$27.07

Volume: 1.48 million shs
Average Volume: 2.32 million shs
Market Capitalization: $7.03 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.44

R1 RCM MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.87 Rating Score
Upside/Downside: 3.7% Upside
$17.44 Price Target
Short Interest: Bearish
10.94% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 0.93
Based on 4 Articles This Week
Insider Trading: Selling Shares
$327,200 Sold Last Quarter
Proj. Earnings Growth: 337.50%
From $0.08 to $0.35 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Business Services Sector

195th out of 337 stocks

Management Services Industry

4th out of 6 stocks

1.4

Analyst's Opinion

Consensus Rating
R1 RCM has received a consensus rating of Buy. The company's average rating score is 2.87, and is based on 13 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $17.44, R1 RCM has a forecasted upside of 3.7% from its current price of $16.81.
Amount of Analyst Coverage
R1 RCM has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
10.94% of the float of R1 RCM has been sold short.
Short Interest Ratio / Days to Cover
R1 RCM has a short interest ratio ("days to cover") of 9.2.
Change versus previous month
Short interest in R1 RCM has recently decreased by 1.03%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
R1 RCM does not currently pay a dividend.
Dividend Growth
R1 RCM does not have a long track record of dividend growth.

3.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
R1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.
Environmental Sustainability
The Environmental Impact score for R1 RCM is -1.33.

2.2

News and Social Media Coverage

News Sentiment
R1 RCM has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for R1 RCM this week, compared to 5 articles on an average week.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $327,200.00 in company stock.
Percentage Held by Insiders
37.00% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
97.09% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for R1 RCM are expected to grow by 337.50% in the coming year, from $0.08 to $0.35 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of R1 RCM is -73.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of R1 RCM is -73.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
R1 RCM has a PEG Ratio of 12.20. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
R1 RCM has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Stock News Headlines

June 1, 2023 | fool.com

R1 Rcm (NASDAQ: RCM)

May 24, 2023 | americanbankingnews.com

R1 RCM Inc. (NASDAQ:RCM) Receives $17.44 Consensus Target Price from Analysts

June 4, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

May 23, 2023 | uk.finance.yahoo.com

Global Healthcare Revenue Cycle Management Market is projected to grow at a Healthy CAGR of ~11-12% by 2027

May 22, 2023 | americanbankingnews.com

Bank of America Raises R1 RCM (NASDAQ:RCM) Price Target to $22.00

May 21, 2023 | americanbankingnews.com

R1 RCM (NASDAQ:RCM) Shares Gap Up Following Analyst Upgrade

May 19, 2023 | markets.businessinsider.com

R1 RCM (RCM) Receives a Buy from Bank of America Securities

May 19, 2023 | cnbc.com

Buy this medical billing stock with more than 30% upside, Bank of America says

June 4, 2023 | Behind the Markets (Ad)

NOTICE: Your retirement is in immediate danger

Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>

May 16, 2023 | marketwatch.com

2023, Healthcare Revenue Cycle Management (RCM) Market | Global Industry Analysis Till 2030

May 15, 2023 | msn.com

R1 RCM's Return On Capital Employed Overview

May 11, 2023 | markets.businessinsider.com

Robert W. Baird Reaffirms Their Buy Rating on R1 RCM (RCM)

May 10, 2023 | americanbankingnews.com

Research Analysts Issue Forecasts for R1 RCM Inc.'s Q3 2023 Earnings (NASDAQ:RCM)

May 10, 2023 | americanbankingnews.com

Deutsche Bank Aktiengesellschaft Increases R1 RCM (NASDAQ:RCM) Price Target to $18.00

May 9, 2023 | marketwatch.com

Healthcare Revenue Cycle Management (RCM) Software Market [2023-2031]| Explore the Future Growth of Industry: An Intelligence Report

May 9, 2023 | americanbankingnews.com

R1 RCM Inc. to Post Q2 2023 Earnings of $0.00 Per Share, KeyCorp Forecasts (NASDAQ:RCM)

May 8, 2023 | marketwatch.com

Revenue Cycle Management (RCM) System Market 2023 (New Report) is Poised to Experience Huge Global Growth from 2023 to 2031

May 7, 2023 | seekingalpha.com

R1 RCM Inc. 2023 Q1 - Results - Earnings Call Presentation

May 6, 2023 | msn.com

Morgan Stanley Maintains R1 RCM (RCM) Equal-Weight Recommendation

May 6, 2023 | finance.yahoo.com

R1 RCM Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

May 5, 2023 | msn.com

Truist Securities Maintains R1 RCM (RCM) Hold Recommendation

May 5, 2023 | marketwatch.com

Healthcare RCM Outsourcing Market Future Growth and Business Opportunities 2023 | Updated Report

May 4, 2023 | finance.yahoo.com

R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q1

May 4, 2023 | finanznachrichten.de

R1 RCM Inc.: R1 RCM Reports First Quarter 2023 Results

May 4, 2023 | msn.com

R1 RCM GAAP EPS of $0.00 beats by $0.02, revenue of $545.6M misses by $2.61M

May 4, 2023 | msn.com

R1 RCM: Q1 Earnings Insights

May 4, 2023 | finance.yahoo.com

R1 RCM Reports First Quarter 2023 Results

See More Headlines

RCM Price History

30 days | 90 days | 365 days | Advanced Chart

RCM Company Calendar

Last Earnings: 2/16/2023
Today: 6/04/2023
Next Earnings (Estimated): 8/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Management services
Sub-Industry: Health Care Services
Sector: Business Services
Current Symbol: NASDAQ:RCM
Previous Symbol: NYSE:RCM
CUSIP: 00438V10
CIK: 1472595
Web: www.r1rcm.com
Phone: (312) 324-7820
Fax: 302-655-5049
Employees: 27,800
Year Founded: 2003

Price Target and Rating

Average Stock Price Forecast: $17.44
High Stock Price Forecast: $25.00
Low Stock Price Forecast: $10.00
Forecasted Upside/Downside: +3.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.87
Research Coverage: 15 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 210.13
P/E Growth: 11.93
Net Income: $-57,600,000.00
Net Margins: -4.41%
Pretax Margin: -4.91%
Return on Equity: -1.02%
Return on Assets: -0.55%

Debt

Debt-to-Equity Ratio: 0.63
Current Ratio: 1.71
Quick Ratio: 1.71

Sales & Book Value

Annual Sales: $1.81 billion
Price / Sales: 3.89
Cash Flow: $0.29 per share
Price / Cash Flow: 57.99
Book Value: $6.50 per share
Price / Book: 2.59

Miscellaneous

Outstanding Shares: 418,200,000
Free Float: 263,468,000
Market Cap: $7.03 billion
Optionable: Not Optionable
Beta: 0.84

Social Links

Key Executives

Lee Rivas
Chief Executive Officer & Director

John Sparby
President

Kristina Bourke
Executive Vice President-Operations

Jennifer Williams
Chief Financial Officer & EVP

Harvey Ewing
Chief Information Officer & Executive VP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?: 15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RCM shares.
View RCM analyst ratings or view top-rated stocks.
What is R1 RCM's stock price forecast for 2023?: 15 Wall Street analysts have issued 1-year target prices for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $25.00. On average, they predict the company's stock price to reach $17.44 in the next year. This suggests a possible upside of 3.7% from the stock's current price.
View analysts price targets for RCM or view top-rated stocks among Wall Street analysts.
How have RCM shares performed in 2023?: R1 RCM's stock was trading at $10.95 at the beginning of 2023. Since then, RCM shares have increased by 53.5% and is now trading at $16.81.
View the best growth stocks for 2023 here.
When is R1 RCM's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our RCM earnings forecast.
How were R1 RCM's earnings last quarter?: R1 RCM Inc. (NASDAQ:RCM) posted its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The healthcare provider had revenue of $532.80 million for the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a negative trailing twelve-month return on equity of 1.02% and a negative net margin of 4.41%. R1 RCM's revenue was up 33.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.11 earnings per share.
What ETFs hold R1 RCM's stock?: ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Thrivent Small-Mid Cap ESG ETF (TSME), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS), ERShares NextGen Entrepreneurs ETF (ERSX), Invesco NASDAQ Next Gen 100 ETF (QQQJ), RiverNorth Patriot ETF (FLDZ) and BlackRock Future Health ETF (BMED).
What guidance has R1 RCM issued on next quarter's earnings?: R1 RCM updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.28 billion-$2.33 billion, compared to the consensus revenue estimate of $2.31 billion.
What is Joseph Flanagan's approval rating as R1 RCM's CEO?: 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?: Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).
What is R1 RCM's stock symbol?: R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
Who are R1 RCM's major shareholders?: R1 RCM's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.22%), FMR LLC (1.91%), Sachem Head Capital Management LP (1.78%), American Century Companies Inc. (1.77%), Bank of New York Mellon Corp (1.53%) and State Street Corp (1.18%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Lee Rivas, Michael C Feiner and Richard B Jr Evans.
View institutional ownership trends.
How do I buy shares of R1 RCM?: Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is R1 RCM's stock price today?: One share of RCM stock can currently be purchased for approximately $16.81.
How much money does R1 RCM make?: R1 RCM (NASDAQ:RCM) has a market capitalization of $7.03 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis.
How many employees does R1 RCM have?: The company employs 27,800 workers across the globe.
Does R1 RCM have any subsidiaries?: The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?: R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 6/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial